Differential expression of inducible nitric oxide synthase and peroxisome proliferator-activated receptor gamma in non-small cell lung carcinoma

By Lee T.W.   Chen G.G.   Xu H.   Yip J.H.Y.   Chak E.C.W.   Mok T.S.K.   Yim A.P.C.  

European Journal of Cancer, Vol. 39, Iss. 9, 2003-06 ,pp. : 1296-1301

Elsevier

Access to resources Recommend Favorite

Growth Inhibition and Differentiation Induced by Peroxisome Proliferator Activated Receptor Gamma Ligand Rosiglitazone in Human Melanoma Cell Line A375

By  

Medical Oncology, Vol. 23, Iss. 3, 2006-09 ,pp. : 393-402

Humana Press, Inc

Access to resources Recommend Favorite

Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers

By Yokoyama Yoshihito   Xin Bing   Shigeto Tatsuhiko   Mizunuma Hideki  

Journal of Cancer Research and Clinical Oncology, Vol. 137, Iss. 8, 2011-08 ,pp. : 1219-1228

Springer Publishing Company

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptors and their Ligands in Cancer Drug- Resistance: Opportunity or Challenge

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 12, 2016-12 ,pp. : 1541-1548

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor γ ligands inhibit VEGF-mediated vasculogenic mimicry of prostate cancer through the AKT signaling pathway

By                  

Molecular Medicine Reports, Vol. 10, Iss. 1, 2014-01 ,pp. : 276-282

Spandidos Publications

Access to resources Recommend Favorite